Clinical Trial Update: A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts [Phase 2]

View source ↗

Summary

Phase 2 trial of A-101 Topical Solution for common warts has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Wart

Drugs mentioned

• A-101 Topical Solution

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Common Wart | Phase 2 | Status: COMPLETED | Results posted: 2019-03-29